DNA methylation episignatures are sensitive and specific biomarkers for detection of patients with KAT6A/ KAT6B variants
- PMID: 37249002
- DOI: 10.2217/epi-2023-0079
DNA methylation episignatures are sensitive and specific biomarkers for detection of patients with KAT6A/ KAT6B variants
Abstract
Accurate diagnosis for patients living with neurodevelopmental disorders is often met with numerous challenges, related to the ambiguity of findings and lack of specificity in genetic variants leading to pathology. Genome-wide DNA methylation analysis has been used to develop highly sensitive and specific 'episignatures' as biomarkers capable of differentiating and classifying complex neurodevelopmental disorders. In this study we describe distinct episignatures for KAT6A syndrome, caused by pathogenic variants in the lysine acetyltransferase A gene (KAT6A), and for the two neurodevelopmental disorders associated with lysine acetyl transferase B (KAT6B). We demonstrate the ability of our models to differentiate between highly overlapping episignatures, increasing the ability to effectively identify and diagnose these conditions.
Keywords: DNA methylation; KAT6A; epigenetics; episignature.
Similar articles
-
The key roles of the lysine acetyltransferases KAT6A and KAT6B in physiology and pathology.Drug Resist Updat. 2020 Dec;53:100729. doi: 10.1016/j.drup.2020.100729. Epub 2020 Oct 7. Drug Resist Updat. 2020. PMID: 33130515 Review.
-
Gene domain-specific DNA methylation episignatures highlight distinct molecular entities of ADNP syndrome.Clin Epigenetics. 2019 Apr 27;11(1):64. doi: 10.1186/s13148-019-0658-5. Clin Epigenetics. 2019. PMID: 31029150 Free PMC article.
-
DNA methylation analysis in patients with neurodevelopmental disorders improves variant interpretation and reveals complexity.HGG Adv. 2024 Jul 18;5(3):100309. doi: 10.1016/j.xhgg.2024.100309. Epub 2024 May 15. HGG Adv. 2024. PMID: 38751117 Free PMC article.
-
Evaluation of DNA Methylation Episignatures for Diagnosis and Phenotype Correlations in 42 Mendelian Neurodevelopmental Disorders.Am J Hum Genet. 2020 Mar 5;106(3):356-370. doi: 10.1016/j.ajhg.2020.01.019. Epub 2020 Feb 27. Am J Hum Genet. 2020. PMID: 32109418 Free PMC article.
-
Diagnostic Utility of Genome-Wide DNA Methylation Analysis in Mendelian Neurodevelopmental Disorders.Int J Mol Sci. 2020 Dec 6;21(23):9303. doi: 10.3390/ijms21239303. Int J Mol Sci. 2020. PMID: 33291301 Free PMC article. Review.
Cited by
-
Methylation assay in KMT2B-related dystonia: a novel diagnostic validation tool.Clin Epigenetics. 2024 Nov 25;16(1):169. doi: 10.1186/s13148-024-01780-1. Clin Epigenetics. 2024. PMID: 39587624 Free PMC article.
-
ERα status of invasive ductal breast carcinoma as a result of regulatory interactions between lysine deacetylases KAT6A and KAT6B.Sci Rep. 2024 Nov 6;14(1):26935. doi: 10.1038/s41598-024-78432-0. Sci Rep. 2024. PMID: 39505971 Free PMC article.
-
FBRSL1 regulates the expression of chromatin regulators BRPF1 and KAT6A.Hum Genet. 2025 Jul 14. doi: 10.1007/s00439-025-02760-y. Online ahead of print. Hum Genet. 2025. PMID: 40658195
-
Chromatinopathies: insight in clinical aspects and underlying epigenetic changes.J Appl Genet. 2024 May;65(2):287-301. doi: 10.1007/s13353-023-00824-1. Epub 2024 Jan 5. J Appl Genet. 2024. PMID: 38180712 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous